Executive Compensation | Amgen


At Amgen, we are interested in feedback from our stockholders on our executive compensation policies and practices. These policies and practices are described in our 2024 Proxy Statement under "Compensation Discussion and Analysis" (a link to our 2024 Proxy Statement is provided below).

To give us feedback on these policies and practices please click here. As in past years, responses from our stockholders will be reviewed and shared with the Compensation and Management Development Committee of our Board of Directors.

2023 Annual Report

2024 Proxy Statement